ArticlePloS one2015

A phase I dose-escalation study of lenalidomide in combination with gemcitabine in patients with advanced pancreatic cancer.

Gustav J Ullenhag et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.